Booth Andrew
- SEC CIK
- 0001834411
In the past year, 2 open-market purchase filings worth $529.6K and no sales.
Current role at each company
- ABCL AbCellera Biologics Inc.Chief Financial Officeras of Aug 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $529.6K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$529.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Booth Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 (view filing)12:04 PM ET | Aug 14 | Same day | Booth AndrewChief Financial Officer | PPurchase | +37.2K | $10.32 | +$383.9K | +8.3%482.8K after | |
| Feb 27, 2026 (view filing) | Feb 27 | Same day | Booth AndrewChief Financial Officer | PPurchase | +42.6K | $3.42 | +$145.7K | +27.8%195.6K after | |
| May 26, 2023 (view filing) | May 26 | Same day | Booth AndrewChief Financial Officer | PPurchase | +14.5K | $6.85 | +$99.3K | +10.5%153.0K after | |
| May 16, 2022 (view filing) | May 12 | 4 days | Booth AndrewChief Financial Officer | PPurchase | +85.0K | $5.79 | +$492.1K | +158.9%138.5K after | |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Booth AndrewChief Financial Officer | PPurchase | +53.5K | $14.74 | +$788.6K | New position53.5K after | |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Booth AndrewChief Financial Officer | PPurchase | +14.0K | $14.61 | +$204.5K | +12.0%131.0K after |